G0726L117
Organogenesis Holdings Inc.
Could not find a ticker for this position, may be a filing error
A regenerative medicine company that grows living skin and tissue products to help wounds heal. Its best-known product, Apligraf, is a living skin substitute used to treat diabetic foot ulcers and venous leg ulcers, while its PuraPly and Affinity lines provide antimicrobial and amniotic membrane dressings for surgeons and wound-care clinics. Founded in 1985 in Massachusetts, the company's name reflects its founding mission of growing organs and tissues in the lab rather than just making bandages.
WARRANTUnderlying: AHPACINS: G0726L117HealthcareUS1 holder
Warrant to purchase one-half of one Class A ordinary share, expiring approximately October 7, 2026
Recent Activity
2018Q4
1 sell
-509.2K shares
-509.2K shares
2018Q3
1 sell
-1.64M shares(-76.3%)
-1.64M shares(-76.3%)
2018Q1
1 buy
+5.6K shares(+0.3%)
+5.6K shares(+0.3%)
Loading more activity...